Nyle Institute Of Medical Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 24-12-2024
- Paid Up Capital ₹ 0.10 M
as on 24-12-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.50 Cr
as on 24-12-2024
- Revenue 28.58%
(FY 2020)
- Profit 6594.44%
(FY 2020)
- Ebitda 90.82%
(FY 2020)
- Net Worth 48.26%
(FY 2020)
- Total Assets 6.69%
(FY 2020)
About Nyle Institute Of Medical Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹4.50 Cr.
Thindiparambath Jitha and Vaikathukatil Aloke serve as directors at the Company.
- CIN/LLPIN
U85110KL2015PTC038142
- Company No.
038142
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Thrissur, Kerala, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Nyle Institute Of Medical Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vaikathukatil Aloke  | Managing Director | 12-Mar-2015 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thindiparambath Jitha | Director | 12-Mar-2015 | Current |
Financial Performance of Nyle Institute Of Medical Sciences.
Nyle Institute Of Medical Sciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 28.58% increase. The company also saw a substantial improvement in profitability, with a 6594.44% increase in profit. The company's net worth Soared by an impressive increase of 48.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nyle Institute Of Medical Sciences?
In 2019, Nyle Institute Of Medical Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Travancore Creation Date: 02 Mar 2016 | ₹1.00 Cr | Open |
State Bank Of Travancore Creation Date: 02 Mar 2016 | ₹1.00 Cr | Open |
State Bank Of India Creation Date: 02 Mar 2016 | ₹2.50 Cr | Open |
How Many Employees Work at Nyle Institute Of Medical Sciences?
Nyle Institute Of Medical Sciences has a workforce of 71 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nyle Institute Of Medical Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nyle Institute Of Medical Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
